Please use this identifier to cite or link to this item:
Title: Leptomeningeal neuraxis relapse in glioblastoma is an uncommon but not rare event associated with poor outcome
Authors: Wegener, Eric;Horsley, Patrick;Wheeler, Helen;Jayamanne, Dasantha ;Kastelan, Marina;Guo, Linxin;Brown, Chris;Back, Michael 
Affliation: Central Coast Local Health District
Gosford Hospital
Issue Date: 15-Sep-2023
Source: 23(1):328
Journal title: BMC Neurology
Department: Radiation Oncology
Abstract: Spinal neuraxis leptomeningeal metastasis (LM) relapse in glioblastoma is an uncommon event that is challenging to manage. This study aims to determine the incidence, associated factors, and outcome of LM relapse in patients with glioblastoma managed with radical intent. Patients managed for glioblastoma using the EORTC-NCIC (Stupp) Protocol from 2007 to 2019 were entered into a prospective ethics-approved database. Follow-up included routine cranial MRI surveillance with further imaging as clinically indicated. LM relapse was determined by MRI findings and/or cerebrospinal fluid analysis. The chi-square test of independence was used to evaluate clinico-pathologic factors associated with increased risk of subsequent LM relapse. Median survival post-LM relapse was calculated using Kaplan-Meier technique. Four-hundred-and-seven patients were eligible, with median follow-up of 60 months for surviving patients. Eleven (2.7%) had LM at first relapse and in total 21 (5.1%) experienced LM in the entire follow-up period. Sites of LM relapse were 8 (38%) focal spinal, 2 (10%) focal brainstem medulla and 11 (52%) diffuse spinal. Median overall survival from initial diagnosis for the entire cohort was 17.6 months (95% CI 16.7-19.0). Median survival from LM relapse to death was 39 days (95% CI: 19-107). Factors associated with LM relapse were age less than 50 years (p < 0.01), initial disease located in the temporal lobe (p < 0.01) and tumours lacking MGMT promoter methylation (p < 0.01). LM relapse is an uncommon but not rare event in patients managed radically for glioblastoma. It is associated with poor outcome with the majority of patients deceased within two months of recognition.
DOI: 10.1186/s12883-023-03378-1
Publicaton type: Journal Article
Keywords: Cancer
Appears in Collections:Oncology / Cancer

Show full item record

Page view(s)

checked on Apr 20, 2024

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.